Xenon Pharmaceuticals
XENE
$43.16
Share price
0.38%
Change (1 day)
7.43%
Change (1 year)
Categories
Xenon Pharmaceuticals (XENE) - Cash on Hand
Cash on Hand as of December 2023 : $0.63 B
According to Xenon Pharmaceuticals's latest financial reports the company has $0.63 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Xenon Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.63 B | 7.77% |
| 2022-12-31 | $0.59 B | 7.31% |
| 2021-12-31 | $0.55 B | 211.74% |
| 2020-12-31 | $0.17 B | 25.21% |
| 2019-12-31 | $0.14 B | 18.48% |
| 2018-12-31 | $0.11 B | 173.22% |
| 2017-12-31 | $43.66 M | -31.93% |
| 2016-12-31 | $64.14 M | 9.37% |
| 2015-12-31 | $58.65 M | -30.21% |
| 2014-12-31 | $84.04 M | 70.55% |
| 2013-12-31 | $49.27 M | -18.09% |
| 2012-12-31 | $60.16 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | $0.11 B | -81.55% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | $51.72 M | -91.89% | 🇺🇸 USA |